Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Qingfeng Yu"'
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
ObjectiveTo investigate an optimal regimen of six drugs, including lactoferrin, probiotics, prebiotics, glutamine, arginine and erythropoietin (EPO), for the prevention of necrotizing enterocolitis (NEC) in preterm infants.MethodsPubMed, Embase, Ovid
Externí odkaz:
https://doaj.org/article/84df9eddf38d4432899702bc20d0cdf0
Autor:
Jie Ma, Mengmeng Zhang, Xiaoyan Liu, Wu Ye, Jili Deng, Feifei Wu, Congli Zhang, Qingfeng Yu, Li Cao, Silin Gan
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Objectives Multiple myeloma (MM) is a malignant plasma cell disorder. The most widely accepted staging system for MM is the revised International Staging System based on cytogenetic and clinical biomarkers. The circulating clonal plasma cells (CPCs)
Externí odkaz:
https://doaj.org/article/4d36ae80d4154bbdbb448c74bf17934b
Publikováno v:
Frontiers in Urology, Vol 3 (2023)
Externí odkaz:
https://doaj.org/article/0ee068923c144aac9efa932d5e6002cb
Autor:
Qingfeng Yu, Chengjie Wu, Yeda Chen, Bingsheng Li, Ruixiao Wang, Ru Huang, Xuechun Li, Di Gu, Xiaolong Wang, Xiaolu Duan, Shujue Li, Yang Liu, Wenqi Wu, Martin Hennenberg, Guohua Zeng
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 7, Pp 1914-1930 (2021)
Overactive bladder (OAB) is the most bothersome symptom in lower urinary tract symptoms (LUTS). Current pharmacologic treatment aims to inhibit detrusor contraction; however, shows unsatisfied efficacy and high discontinuation rate. LIM kinases (LIMK
Externí odkaz:
https://doaj.org/article/45acd86a838d49659c591eec4b20cd77
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: The clinical value of the biomarkers of bladder cancer (BC) is limited due to their low sensitivity or specificity. As a biomarker, DLG associated protein 5 (DLGAP5) is a potential cell cycle regulator in cancer cell carcinogenesis. Howev
Externí odkaz:
https://doaj.org/article/2128dd7368a04ee9bcc76012d6d22be8
Autor:
Ziyu Liu, Zhiyuan Guan, Hongyu Lan, Yan Zhao, Zhiming Ye, Daojun Lv, Qingfeng Yu, Ming Wang, Kaoqing Peng, Nanfei Fu, Giorgio Mazzon, Di Gu
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundThe Visual Prostate Symptom Score (VPSS) is used for the assessment of lower urinary tract symptoms (LUTS). It is usually administered by general practitioners (GPs), but in these cases, outcomes do not seem to be reflecting the real condit
Externí odkaz:
https://doaj.org/article/af22c86a9fe44ceda121d5b3d11cfc2c
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Upper urinary tract stones is the most common diseases in urology. Percutaneous nephrolithotomy (PCNL) and ureteroscopic lithotripsy (fURL) are common treatment, but both their efficacy and safety are controversial. Thus we aim to
Externí odkaz:
https://doaj.org/article/1b07aa28b77549d399e1629325985c28
Autor:
Zhaoxing Wu, Haifeng Zhuang, Qingfeng Yu, Xuzhao Zhang, Xudong Jiang, Xiaoya Lu, Ying Xu, Linlin Yang, Bowen Wu, An Ma, Lei Zhang, Xibin Xiao, Yun Liang, Ruilan Gao, Jianping Shen, Rongzhen Xu
Publikováno v:
Translational Oncology, Vol 12, Iss 6, Pp 801-809 (2019)
As a heterogeneous group of clonal disorders, acute myeloid leukemia with internal tandem duplication of fms-like tyrosine kinase 3 (FLT3-ITD) mutation usually shows an inferior prognosis. In the present study, we found that homoharringtonine (HHT),
Externí odkaz:
https://doaj.org/article/50eb55464a5c4aaea816fe50ef184d60
Autor:
Bingsheng Li, Qingfeng Yu, Ruixiao Wang, Christian Gratzke, Xiaolong Wang, Annabel Spek, Annika Herlemann, Alexander Tamalunas, Frank Strittmatter, Raphaela Waidelich, Christian G. Stief, Martin Hennenberg
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
IntroductionLower urinary tract symptoms (LUTS) due to overactive bladder (OAB) are caused by spontaneous detrusor contractions. Medical treatment with muscarinic receptor antagonists or β3-adrenoceptor agonists aims to inhibit detrusor contractions
Externí odkaz:
https://doaj.org/article/e23cb2badbc447bba5db1016c2fee81f
Autor:
Qingfeng Yu, Ping Wang, Linlin Yang, Zhaoxing Wu, Shu Li, Ying Xu, Bowen Wu, An Ma, Xiaoxian Gan, Rongzhen Xu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 117, Iss , Pp - (2019)
Proto-oncogene Myc, a key transcription factor, is frequently deregulated in human leukemia with aggressive and poor clinical outcome, but the development of MYC inhibitors remains challenging due to MYC helix-loop-helix topology lacking druggable do
Externí odkaz:
https://doaj.org/article/00c32fcc034f4436b3bd8511ca8e0fa6